Accelerated TMS for Treatment-Resistant ECT — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Accelerated TMS for Treatment-Resistant ECT — Stella

Home/Major Depressive Disorder (MDD)/

View on ClinicalTrials.gov

Recruiting

Back to Major Depressive Disorder (MDD) trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Belgium

UZ Brussel, Jette, Brussels Capital

Key details

Sponsor

Universitair Ziekenhuis Brussel

Enrollment target

~200 participants

Started

October 2025

Primary completion

December 2027

Age range

18 Years – 70 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.